These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2044501)

  • 1. Felbamate: a clinical trial for complex partial seizures.
    Theodore WH; Raubertas RF; Porter RJ; Nice F; Devinsky O; Reeves P; Bromfield E; Ito B; Balish M
    Epilepsia; 1991; 32(3):392-7. PubMed ID: 2044501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate for partial seizures: results of a controlled clinical trial.
    Leppik IE; Dreifuss FE; Pledger GW; Graves NM; Santilli N; Drury I; Tsay JY; Jacobs MP; Bertram E; Cereghino JJ
    Neurology; 1991 Nov; 41(11):1785-9. PubMed ID: 1944909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate monotherapy: implications for antiepileptic drug development.
    Theodore WH; Albert P; Stertz B; Malow B; Ko D; White S; Flamini R; Ketter T
    Epilepsia; 1995 Nov; 36(11):1105-10. PubMed ID: 7588454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats.
    Wlaź P; Löscher W
    Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felbamate monotherapy: controlled trial in patients with partial onset seizures.
    Sachdeo R; Kramer LD; Rosenberg A; Sachdeo S
    Ann Neurol; 1992 Sep; 32(3):386-92. PubMed ID: 1416808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate in refractory partial epilepsy.
    Canger R; Vignoli A; Bonardi R; Guidolin L
    Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome.
    Siegel H; Kelley K; Stertz B; Reeves-Tyer P; Flamini R; Malow B; Gaillard WD; Ko D; Theodore WH
    Epilepsy Res; 1999 Apr; 34(2-3):91-7. PubMed ID: 10210023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.
    Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A
    Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.